In the UK, a coalition of top industry groups, including the Cannabis Industry Council (CIC), Medical Cannabis Clinicians Society (MCCS), Volteface, and Maple Tree Consultants, launched a new campaign that aims to grant general practitioners (GPs) the authority to prescribe medical cannabis to their patients.

Dubbed the 'Protect our Patients' campaign, it aims to extend the same prescription rights to GPs that consultants have. “The current model for medical cannabis where only consultants can prescribe is simply not working in the interests of the majority of patients,” said Professor Mike Barnes, who founded both the MCCS and CIC.

However, Barnes believes that …

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.